JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2006) 190, 711-718       DOI: 10.1677/joe.1.06389
© 2006 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delva, P
Right arrow Articles by Lechi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delva, P
Right arrow Articles by Lechi, A

Insulin and glucose mediate opposite intracellular ionized magnesium variations in human lymphocytes

P Delva, M Degan, M Trettene and A Lechi

Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro, 37134 Verona, Italy

(Requests for offprints should be addressed to P Delva; Email: pietro.delva{at}univr.it)

Insulin is capable of increasing intracellular magnesium, although very little is known about the effect of insulin on the biologically active fraction of magnesium, i.e. the ionized quota (Mgi2+), its interactions with glucose, and the cellular mechanisms involved in these processes. We studied the interactions of the effects of insulin and glucose on intracellular ionized magnesium in human lymphocytes. Mgi2+ was measured using a fluorimetric method and the Mg2+-sensitive dye, furaptra. We found that insulin significantly increases the Mgi2+(without insulin 227 ± 14 µM, with 10 µU/ml, insulin 301 ± 30 µM, P<0.0001, n = 12) in a dose-dependent manner in all three glucose concentrations tested (5, 7 and 15 mmol/l). The half-maximal effect of insulin was approximately 0.8 µU/ml. Glucose and insulin showed opposite effects in their ability to modify Mgi2+ in lymphocytes. Inhibitors of the membrane Na+- Mg2+ transport system and of phosphatidylinositol (PI) 3-kinase abolish the insulin-mediated increase of Mgi2+, thus suggesting that insulin is capable of increasing Mgi2+ by modulating the activity of this transport system, possibly through the mediation of PI 3-kinase activation. Taking into account the relationship between insulin and glucose plasma levels and their opposing effects on Mgi2+, this mechanism may represent the two limbs of a biphasic regulatory system of Mgi2+ in both physiological and pathological conditions.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.